Medifast (MED) Interest Expenses (2010 - 2026)

Medifast's Interest Expenses history runs 17 years deep, the most recent figure standing at $18.1 million for Q1 2026.

• Quarterly Interest Expenses rose 20.4% year-over-year to $18.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (up 20.4% YoY) and the FY2025 annual result came in at $13.7 million, up 116.89% from the prior year.
• Interest Expenses was $18.1 million for Q1 2026 at Medifast, up from $1.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $30.9 million in Q2 2022 and bottomed at $624000.0 in Q3 2024.
• A 5-year average of $13.0 million and a median of $13.4 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses sank 97.33% — and 2025, when it surged 1930.61%.
• Medifast's Interest Expenses stood at $1.8 million in 2022, then declined by 16.29% to $1.5 million in 2023, then gained by 6.56% to $1.6 million in 2024, then grew by 2.39% to $1.6 million in 2025, then soared by 1011.47% to $18.1 million in 2026.
• Business Quant data shows MED's Interest Expenses at $18.1 million in Q1 2026, $1.6 million in Q4 2025, and $12.7 million in Q3 2025.